5 of Last Week's Biggest Losers
These five stocks bucked last week's uptrend by taking a dive.
The Best of 2012 #7: Sunesis
After announcing an expansion of P3 trials for its acute myeloid leukemia drug, Sunesis Pharmaceuticals shot to new heights, up 325% for the year. That puts it at #7 on our list of the very best stocks in healthcare for 2012.